AUKUS and nuclear non-proliferation
Whether Australia leases, buys or builds nuclear-fuelled submarines as part of the AUKUS pact with the United Kingdom and the United States, it will be the first non-nuclear state to do so. How nuclear non-proliferation issues are addressed by these three countries is not the sole test of AUKUS, but it will form an important part of managing its future trajectory and global reception.
Join us for an in-person conversation with Dr Alan J. Kuperman, Associate Professor at the Lyndon B. Johnson School of Public Affairs in Texas, and Hervé Lemahieu, Director of Research at the Lowy Institute. They will discuss the implications of AUKUS for the nuclear non-proliferation regime and examine how the current negotiations with the International Atomic Energy Agency in Vienna aim to mitigate any proliferation risks stemming from AUKUS.
Dr Alan J. Kuperman is Associate Professor of Public Affairs and founding coordinator of the Nuclear Proliferation Prevention Project at the LBJ School of Public Affairs at the University of Texas. He was previously Senior Policy Analyst for the nongovernmental Nuclear Control Institute, and Legislative Director for Rep. Charles Schumer in the US Congress. He holds an AB in Physical Sciences from Harvard University, an MA in International Relations and International Economics from Johns Hopkins University, and a PhD in Political Science from the Massachusetts Institute of Technology. He has authored and edited books including Plutonium for Energy? Explaining the Global Decline of MOX (2018) and Nuclear Terrorism and Global Security: The Challenge of Phasing out Highly Enriched Uranium (2013).
WHEN & WHERE
- Monday 14 March 2022, 12:30pm for 12:45pm to 1:45pm
- Lowy Institute, 31 Bligh Street, Sydney NSW
Lowy Institute Covid-19 entrance requirements: We are mindful of the health and safety of our guests and staff. We respectfully ask that all guests are fully vaccinated and that you do not attend any events if you are unwell or have had any contact with a suspected or known Covid-19 case.